Keywords: AstraZeneca, Regulus Thera, MicroRNA therapeutics, Alliance, Atherosclerosis

AstraZeneca aligns with Regulus for microRNA therapeutics

Article | 16 August 2012

Print This

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and US biotech firm Regulus Therapeutics have signed a strategic alliance for the discovery, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in